Llwytho...
Mitigating off-target effects in CRISPR/Cas9-mediated in vivo gene editing
The rapid advancement of genome editing technologies has opened up new possibilities in the field of medicine. Nuclease-based techniques such as the CRISPR/Cas9 system are now used to target genetically linked disorders that were previously hard-to-treat. The CRISPR/Cas9 gene editing approach wields...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Mol Med (Berl) |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Springer Berlin Heidelberg
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7220873/ https://ncbi.nlm.nih.gov/pubmed/32198625 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00109-020-01893-z |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|